Relfen 60mg Tablet
Prescription Required
Product introduction
Relfen 60mg Tablet is a medicine used in the treatment and prevention of osteoporosis in postmenopausal women. It helps in preventing bone loss that can develop in women after menopause. It makes the bone stronger and lowers the risk of fractures.
It is Selective estrogen receptor modulators (SERM) used in osteoprosis
It is Selective estrogen receptor modulators (SERM) used in osteoprosis
Uses of Relfen Tablet
Benefits of Relfen Tablet
In Treatment and prevention of Post menopausal osteoporosis
Osteoporosis is a common condition that weakens bones, making them fragile and more likely to break. It often occurs in women after menopause (end of a woman's menstrual cycles) and is known as post-menopausal osteoporosis. Relfen 60mg Tablet helps to keep your bones strong and healthy and reduces the risk of osteoporosis. It also helps maintain bone density and reduces your risk of bone fracture. You should use this medicine as it is prescribed, and for as long as it is prescribed by your doctor.
Side effects of Relfen Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Relfen
- Leg cramps
- Peripheral edema
- Flu-like symptoms
- Joint pain
- Sweating
- Hot flashes
How to use Relfen Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Relfen 60mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Relfen 60mg Tablet. Please consult your doctor.
Pregnancy
UNSAFE
Relfen 60mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
UNSAFE
Relfen 60mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
SAFE
Relfen 60mg Tablet does not usually affect your ability to drive.
Kidney
CAUTION
Relfen 60mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Relfen 60mg Tablet may be needed. Please consult your doctor.
Use of Relfen 60mg Tablet is not recommended in patients with severe kidney disease.
Use of Relfen 60mg Tablet is not recommended in patients with severe kidney disease.
Liver
UNSAFE
Relfen 60mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Relfen 60mg Tablet
₹8.5/Tablet
Ralista Tablet
Cipla Ltd
₹12.2/tablet
44% costlier
Bonebay 60mg Tablet
Novartis India Ltd
₹9.55/tablet
12% costlier
Ronal 60mg Tablet
Blue Cross Laboratories Ltd
₹6.88/tablet
19% cheaper
Femoral 60mg Tablet
Duckbill Drugs Pvt Ltd
₹10.14/tablet
19% costlier
Ralosto 60mg Tablet
Abbott L
₹9.99/tablet
18% costlier
Quick tips
- You have been prescribed Relfen 60mg Tablet for the treatment of and prevention of postmenopausal osteoporosis.
- Consult your doctor immediately if you notice lumps in your breast, sudden weakness, chest pain, vision problems, and pain, swelling, warmth, or redness in one or both legs.
- Inform your doctor if you are on estrogen therapy.
- Inform your doctor immediately if you observe bleeding/spotting from the vagina during the treatment.
- Try to increase body movements and do not restrict yourself at one place or position for a long time while taking Relfen 60mg Tablet.
- Remember to do light exercises such as brisk walking to keep yourself active.
- Try to include calcium and vitamin D-rich food in your diet like dairy products, green leafy vegetables, egg yolk or simply get it naturally from sunlight.
- Osteoporosis makes your bones weaker, they may break more easily if you fall. You can try to reduce the risk of falls by wearing well-fitting shoes or slippers and checking your home for hazards such as uneven rugs, trailing wires, and slippery floors.
Fact Box
Chemical Class
Aryl-Phenylketone Derivative
Habit Forming
No
Therapeutic Class
GYNAECOLOGICAL
Action Class
Selective estrogen receptor modulators (SERM)- Osteoporosis
Patient concerns
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Bikle DD. Agents That Affects Bone Mineral Homoestasis. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 766.
- Levin ER, Hammes SR. Estrogens and Progestins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1177-80.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1191-92.
Marketer details
Name: Richie Laboratories Ltd
Address: 5, Devkaran Mansion, 24, Mangaldas Road, Kalbadevi, Mumbai-400002.
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹85
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me